I. Functions and characteristics of the platform
Yunnan drug centralized purchasing platform integrates the drug purchasing demand of the whole province to form scale effect, so as to conduct centralized negotiation and procurement with drug suppliers. The platform has the following functions and features:
1. Centralized procurement: the platform summarizes the drug procurement needs of medical institutions at all levels in the province, forms a unified purchase order, realizes centralized procurement and improves procurement efficiency.
2. Openness and transparency: The platform adopts public bidding, competitive negotiation and other methods to ensure the openness, fairness and impartiality of the procurement process and prevent corruption.
3. Optimize supply chain management: the platform establishes a long-term and stable cooperative relationship with drug suppliers, optimizes supply chain management, and ensures stable drug quality and supply.
4. Reduce the price of drugs: Through centralized procurement and negotiation, the platform helps to reduce the procurement cost of drugs, thereby reducing the price of drugs and reducing the burden on patients.
Second, the platform operation process
The operation flow of Yunnan centralized drug collection platform mainly includes the following steps:
1. demand summary: medical institutions at all levels submit the drug procurement demand to the platform, and the platform summarizes and analyzes the demand.
2. Bidding and negotiation: The platform issues a bidding announcement or conducts competitive negotiation according to the summarized procurement demand, and invites drug suppliers to participate in bidding or negotiation.
3. Review and selection: The platform organizes experts to review the bidding or negotiation results, and selects drug suppliers with high quality and low price for cooperation.
4. Signing contracts and purchasing: The platform signs purchasing contracts with the selected drug suppliers and purchases drugs according to the contract.
5. Distribution and settlement: The drug supplier will distribute the drugs to the designated medical institutions according to the contract requirements, and the platform will settle the payment with the supplier.
Third, the significance and influence of the platform
The establishment and implementation of centralized drug collection platform in Yunnan Province has had a positive impact on drug procurement and medical system in Yunnan Province:
1. Reduce drug prices: Through centralized procurement and negotiation, the platform effectively reduces the procurement cost of drugs, thus reducing drug prices and benefiting patients.
2. Improve procurement efficiency: The platform realizes centralization and standardization of procurement process, improves procurement efficiency and reduces procurement cost.
3. Ensuring drug demand: The platform can ensure that the drug demand of medical institutions is met and protect the drug rights and interests of patients.
4. Promote the development of pharmaceutical industry: The establishment of the platform will help promote the healthy development of pharmaceutical industry, optimize industrial structure and improve drug quality.
To sum up:
Through centralized procurement, openness and transparency, and optimization of supply chain management, Yunnan drug centralized procurement platform has achieved the goal of reducing drug prices and improving procurement efficiency, which has had a positive impact on drug procurement and medical system in Yunnan Province. The establishment of the platform is helpful to ensure the drug demand of medical institutions, reduce the drug burden of patients and promote the healthy development of the pharmaceutical industry.
Legal basis:
Drug Administration Law of the People's Republic of China
Article 5 stipulates that:
The State encourages the research and creation of new drugs and protects the legitimate rights and interests of citizens, legal persons and other organizations in the research and development of new drugs.
Drug Administration Law of the People's Republic of China
Article 26 stipulates that:
When purchasing drugs, medical institutions must establish and implement the system of inspection and acceptance of incoming goods, and verify the drug conformity certificate and other marks; Do not meet the requirements, shall not be purchased and used.